Skip to content

Dose-response Enteral Citrulline for Normal Healthy Volunteers and Surgery Patients

Clinical Trial of Enteral Citrulline in Volunteers With Surgical Repair of Ventral Hernias

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00950976
Enrollment
14
Registered
2009-08-03
Start date
2008-03-31
Completion date
2010-08-31
Last updated
2012-04-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nutritional Deficiency

Brief summary

To determine the level of citrulline to produce a given amount of arginine in healthy volunteers and surgical patients. Arginine-related amino acids are expected to increase as a result of increased substrate provided by citrulline.

Interventions

TID for 5 days

TID for 5 days

Sponsors

Société des Produits Nestlé (SPN)
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* adults, male & female, non-pregnant * BMI 18.5-29.9

Exclusion criteria

* cancer * HIV positive

Design outcomes

Primary

MeasureTime frame
Plasma amino acid levels8 hours

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026